Stelliam Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,723,960
Closed -$87M 43
2016
Q1
$87M Sell
1,723,960
-7,860
-0.5% -$385K 2.69% 16
2015
Q4
$87.3M Buy
1,731,820
+544,960
+46% +$27.5M 2.61% 13
2015
Q3
$55.9M Buy
1,186,860
+123,140
+12% +$6.54M 1.39% 32
2015
Q2
$57.8M Buy
+1,063,720
New +$59.7M 1.22% 36

Other funds holding MRK

Stelliam Investment Management's MRK Position: Q2 2016 in Review

Stelliam Investment Management sold out of Merck (MRK) in Q2 2016, closing a stake of 1,723,960 shares — an estimated $87M sold.

Stelliam Investment Management first reported a position in MRK in Q2 2015 and held it in 4 quarters. The position peaked at $87.3M in Q4 2015. 1,761 funds tracked by Wall St. Rank hold MRK as of Q2 2016.

  • Stelliam Investment Management reported no remaining Merck position as of Q2 2016 after selling out during the quarter.
  • Stelliam Investment Management sold 1,723,960 Merck shares in Q2 2016, an estimated $87M.
  • Stelliam Investment Management first reported a position in Merck in Q2 2015 and held it in 4 quarters.
  • Stelliam Investment Management's Merck position peaked at $87.3M in Q4 2015.
  • 1,761 funds tracked by Wall St. Rank held Merck as of Q2 2016.

Based on Stelliam Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.